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Antimicrobial activityFor cationic antimicrobial peptides to become useful therapeutic agents, it is important to understand their
mechanism of action. To obtain high resolution data, this involves studying the structure and membrane
interaction of these peptides in tractable model bacterial membranes rather than directly utilizing more
complex bacterial surfaces. A number of lipid mixtures have been used as bacterial mimetics, including a
range of lipid headgroups, and different ratios of neutral to negatively charged headgroups. Here we examine
how the structure and membrane interaction of aurein 2.2 and some of its variants depend on the choice of
lipids, and how these models correlate with activity data in intact bacteria (MICs, membrane depolarization).
Speciﬁcally, we investigated the structure and membrane interaction of aurein 2.2 and aurein 2.3 in 1:1
cardiolipin/1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (CL/POPG) (mol/mol), as an alter-
native to 1:1 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(POPC)/POPG and a potential model for
Gram positive bacteria such as S. aureus. The structure andmembrane interaction of aurein 2.2, aurein 2.3, and
ﬁve variants of aurein 2.2 were also investigated in 1:1 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethano-
lamine (POPE)/POPG (mol/mol) lipids as a possible model for other Gram positive bacteria, such as Bacillus
cereus. Solution circular dichroism (CD) results demonstrated that the aurein peptides adopted α-helical
structure in all lipid membranes examined, but demonstrated a greater helical content in the presence of
POPE/POPG membranes. Oriented CD and 31P NMR results showed that the aurein peptides had similar
membrane insertion proﬁles and headgroup disordering effects on POPC/POPG and CL/POPG bilayers, but
demonstrated reduced membrane insertion and decreased headgroup disordering on mixing with POPE/
POPG bilayers at low peptide concentrations. Since the aurein peptides behaved very differently in POPE/
POPG membrane, minimal inhibitory concentrations (MICs) of the aurein peptides in B. cereus strain C737
were determined. The MIC results indicated that all aurein peptides are signiﬁcantly less active against B.
cereus than against S. aureus and S. epidermidis. Overall, the data suggest that it is important to use a relevant
model for bacterial membranes to gain insight into the mode of action of a given antimicrobial peptide in
speciﬁc bacteria.+1 604 822 2157.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
In recent years, cationic antimicrobial peptides (AMPs) have
become of wide interest as possible alternatives to currently utilized
antibiotics. In particular, direct-acting antimicrobial host-defense
peptides are being investigated as they are rapid-acting, potent, and
possess an unusually broad spectrum of activity. For these AMPs to
truly become useful, however, much work is needed to understand
their mechanisms of action and reduce the potential for unwanted
toxicity, to make them more resistant to protease degradation and
improve serum half-life, as well as to devise means of manufacturing
them on a large scale in a consistent and cost-effective manner [1].One approach to determining the mode of action of AMPs is to
establish the nature of the interaction of the peptides with
bacterial membranes. However, given that native bacterial mem-
branes consist of many different types of lipids and protein
complexes (with the added complexity in Gram negative bacteria
of two cell envelope membranes), most studies have examined the
mechanism of action for AMPs using model membranes. Over the
years, a number of lipids have been used for such studies including
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) (e.g., aur-
ein 1.2 [2]), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) (e.g., MSI-78 and MSI-594 [3]), 1,2-diphytanoyl-sn-gly-
cero-3-phosphatidylcholine (DPhPC) (e.g., alamethicin [4,5]), and
other diacylphosphatidylcholine membranes (e.g., K2(LA)xK2 [6]),
as well as lipid mixtures such as DMPC/1,2-dimyristoyl-sn-
glycero-3-phospho-(1′-rac-glycerol) (DMPG) (e.g., PGLa [7]),
POPC/1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-
623J.T.J. Cheng et al. / Biochimica et Biophysica Acta 1808 (2011) 622–633glycerol) (POPG) (e.g., MSI-78 and MSI-594 [3]), or 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine (POPE)/POPG [8–13]
to name but a few.
The choice of lipids to mimic a bacterial model membrane depends
on a number of factors. These include the properties of the lipids, such
as hydrophobic bilayer thickness, phase transition temperature, and
miscibility. For example, DMPC and DMPG are often used to investigate
the effect of AMPs on chain melting temperatures, because these lipids
undergo a phase transition at close to room temperature (24 °C) [14].
The properties of lipids are also linked to the techniques used to
investigate antimicrobial peptide–lipid interactions. For instance,
differential scanning calorimetry (DSC) experiments are often per-
formed using DMPC, DMPG, or a mixture of these lipids [14–16],
because routine calorimeters operate in the range of 0–90 °C. DSC
experiments that aim to probe whether antimicrobial peptides induce
membrane curvature are often performed using, e.g., 1,2-dipalmito-
leoyl-sn-glycero-3-phosphoethanolamine (DiPoPE) [14,17]. In some
cases, the choice of lipids also depends on the easewithwhich the lipids
form aligned bilayers, when placed on solid glass or polymer supports.
POPC/POPG mixtures have traditionally been used for 31P NMR studies
in mechanically aligned bilayers because of the ease of preparing
aligned samples [18]. Even so, some studies utilize other materials (e.g.,
naphthalene [19]) or direct rehydration (e.g., 1 μl of water per slide
prior to sample stacking [20]), to help resolve alignment issues in order
to improve lipid bilayer alignment. Finally, to completely describe
peptide-membrane interactions, factors such as, e.g., peptide-to-lipid
ratio, hydration, buffer composition[21], and the nature of the lipid
phase [5] also need to be considered. Ultimately, the choice of lipids
should be dictated by biological relevance: the results obtained from
the biophysical studies should correlate to some extent with assays
performed on live bacteria that assess the actual antimicrobial activity/
mode of killing (e.g., MIC, membrane depolarization).
Given that only a small number of AMPs have been studied
extensively in different membrane environments, the optimal
bacterial model membrane which is at the same time robust and
applicable for a range of methods remains elusive. The quest for
suitable lipids requires a series of peptides for which a large number of
biophysical and activity data are available. A number of studies from
our laboratory have looked at the structure/activity relationships in
the aurein 2 peptide family. Initial studies focused on the structure
and membrane interaction of aurein 2.2 (GLFDIVKKVVGALGSL-
CONH2), aurein 2.3 (GLFDIVKKVVGAIGSL-CONH2), and an inactive
analogue of aurein 2.3 (aurein 2.3-COOH) in DMPC/DMPG and POPC/
POPG bacterial model membranes [22]. The three aurein peptides
maintain highα-helical content in DMPC/DMPG vesicles at all peptide
concentrations, but show reduced α-helical content in POPC/POPG at
low peptide concentrations. We have demonstrated that these
peptides signiﬁcantly perturb 1:1 DMPC/DMPG (mol/mol) mem-
branes, but are less efﬁcient at perturbing 3:1 POPC/POPG (mol/mol)
membranes. A comparison of the trends observed for these three
peptides in model membranes with MIC and diSC35 assay results in
live bacteria (Staphylococcus aureus strain C622) have suggested that
a 1:1 POPC/POPG (mol/mol) mixture may be the best model
membrane for studying the mechanism of action of these aurein
peptides against S. aureus.
In addition to the three peptides mentioned above, we have
investigated three related peptides that contain mutations at residue
13 (the one point of difference between aurein 2.2 and aurein 2.3),
denoted L13A, L13V, and L13F, and two peptides with C-terminal
truncations of 3 and 6 residues, denoted aurein 2.2-Δ3 and aurein 2.2-
Δ6, respectively [23]. These peptides were chosen in order to further
deduce how a conservative mutation at residue 13 or the absence/
presence of C-terminal residues may have an impact on the mode of
action. As the data presented therein demonstrates [23], relatively
conservative substitutions at position 13 (from L to A, F, or V) did not
have a considerable effect on structure, membrane interaction, andactivity. Complete removal of residue 13, on the other hand, reduced
the helical content of the peptides in the presence of membrane,
limited the ability of the peptide to insert into membranes, and
abolished the ability of the peptides to kill Gram positive bacteria such
as S. aureus and S. epidermidis. The biophysical component of these
studies was conducted in POPC/POPG model membranes, which was
proposed to be an ideal model bacterial membrane for S. aureus in our
previous studies [22] and in many studies of other antimicrobial
peptides [24–26].
Although phosphatidylcholine/phosphatidylglycerol (PC/PG)
model membranes have been used extensively over the years [2,27–
35], a number of recent studies have adopted other lipids mixtures
proposed to be more “relevant”, including phosphatidylethanolamine
(PE)/PG [8–13] and cardiolipin (CL)/PG [36,37]. Indeed, recent studies
have primarily been conducted in model membranes consisting of
different POPE/POPG ratios [38] (mol/mol or w/w), including 3:1
[8,9,12,13,19], 7:3 [11,17,39], and 3:2 [40], to name a few, and CL/PG.
Therefore, it was important to assess whether these lipid mixtures are
better model membranes than POPC/POPG for the aurein 2 peptide
family. In the study reported here, we have therefore chosen to
compare the structure and membrane interactions of the aurein
peptides in 1:1 POPE/POPG and 1:1 CL/POPG (mol/mol) membranes.
Since 1:1 CL/POPG has been deemed to be a model [41] for Gram-
positive bacteria such as S. aureus [42], the structure and membrane
interaction of aurein 2.2 and aurein 2.3 in this environment was
determined using solution circular dichroism (CD) spectroscopy,
oriented CD (OCD) and solid state 31P NMR methods. The results are
compared to the biophysical data obtained in POPC/POPG and to the
MIC data and membrane depolarization data using S. aureus C622.
Next, the structure and membrane interaction of aurein 2.2, aurein
2.3, and the ﬁve variants of aurein 2.2 described above were also
investigated in 1:1 POPE/POPG (mol/mol) lipids, a possible model for
other Gram positive bacteria, such as Bacillus cereus. The conformation
of these peptides is determined using CD. Oriented CD (OCD) and
solid state 31P NMR studies are again used to examine the interaction
between these peptides and POPE/POPG. The minimal inhibitory
concentration (MIC) of each peptide against B. cereus strain C737 was
determined in order to correlate the behavior of the aurein peptides
observed in model membranes to that observed in the presence of
intact bacteria. In addition, the MICs were determined against P.
aeruginosa (PA01) and E. coli (UB1005), which contain ~60% and ~80%
PE, respectively. Overall, these data allowed us to determine the
relevant model bacterial membranes for studying the behavior of the
aurein peptides in different bacteria, and to better understand how
sequence modulated structure–function relationships in different
model membrane environments.
2. Materials and methods
2.1. Materials
Fmoc-protected amino acids, Wang and Rink resin, 2-(1 H-benzo-
triazol-1-yl)-1,1,3,3-tetramethyluroniumhexaﬂuorophosphate (HBTU)
were purchased from Advanced ChemTech (Louisville, KY). N-hydro-
xybenzotiazhole (HOBt) was obtained from Novabiochem (San Diego,
CA). N,N-dimethylformamide (DMF), dichloromethane (DCM), aceto-
nitrile (AcN) and potassium nitrate were purchased from Fisher
Chemicals (Nepean, ON). N,N-diisopropylethylamine (DIEA), triﬂuor-
oacetic acid (TFA), ethane dithiol (EDT), triethylsilane (TES) were
obtained from Sigma-Aldrich (St. Louis, MO). Mylar plates were made




bovine heart cardiolipin (CL) were purchased from Avanti Polar Lipids
(Alabaster, AL) and obtained dissolved in chloroform.
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2.2.1. Peptide synthesis
Aurein parent and mutant peptides were synthesized as previ-
ously described [43], using a CS Bio Co. peptide synthesizer (Menlo
Park, CA) by the in situ neutralization Fmoc chemistry, using Rink or
Wang resin with double-coupling, as appropriate.
2.2.2. Puriﬁcation
The crude peptide productwas puriﬁed by preparative RP-HPLC on
a Waters 600 system (Waters Limited, Mississauga, ON) with 229 nm
UV detection using a Phenomenex (Torrance, CA) C4 preparative
column (20.0 μm, 2.1 cm×25.0 cm) as previously described [22,43].
The identity of the products was veriﬁed using electrospray ionization
(ESI) mass spectrometry and MALDI-TOF as previously described
[22,43] and conﬁrmed to be≥99% pure. The molecular weights of the
ﬁve aurein mutant peptides in this study (as well as aurein 2.3) can be
found in Table 1 of reference [23].
2.2.3. Solution circular dichroism (CD) sample preparation
Solution CD samples with a constant peptide concentration of
200 uM were prepared in different peptide to lipid (P/L) molar ratios
of 1:15, 1:50, and 1:100, using the 1:1 lipid mixtures of CL/POPG or
POPE/POPG. Appropriate amount of lipids in chloroform were dried
using a stream of nitrogen gas to remove most of the chloroform and
vacuum dried overnight in a 5.0 ml round bottom ﬂask. After adding
450.0 μl of ddH2O and 50 ul of peptide stock solution in ddH2O to
dried lipids, the mixture was sonicated in a water bath for a minimum
of 30 min (until the solution was no longer turbid) to ensure lipid
vesicle formation. For all samples, corresponding background samples
without peptides were prepared for spectral subtraction.
2.2.4. Mechanically oriented sample preparation
Solid state NMR samples were prepared using three different P/L
molar ratios of 1:15, 1:80 and 1:120. The amount of lipids (dissolved
in chloroform) was kept constant at 9.59 μmol. The lipids were dried
using a stream of nitrogen gas to remove most of the chloroform and
vacuum dried overnight in a 5.0 ml round bottom ﬂask. Then, the
appropriate amount of peptide was added and the mixture was
redissolved in 500.0 μl of ddH2O by sonication. The mixture was
deposited in 10.0 μl portions repeatedly onto 9 Mylar plates placed in
a Petri dish. Between depositions, most of ddH2O was evaporated
before the next portion was deposited onto the plate. The plated
samples were then placed in a 93% relative humidity chamber and
were indirectly hydrated by incubating at 37 °C for 6 days (CL/POPG)
or 7 days (POPE/POPG). The humidity of the samples was veriﬁed by
visual inspection. The degree of alignment was veriﬁed by solid state
31P NMR. Consistent sample preparation was veriﬁed by preparing
two to three samples for each lipid composition and peptide
concentration. Finally, the plated samples were wrapped in a thinTable 1
Amino acid sequence and minimal inhibitory concentrations (MICs) in μg/ml of the aurein p
text for experimental details). MICs are given as the most frequently observed value obtain
Peptide Sequence MIC
B. ce
Aurein 2.2 GLFDIVKKVVGALGSL 12
Aurein 2.3 GLFDIVKKVVGAIGSL 12




Aurein 2.2-Δ3 GLFDIVKKVVGAL 6
Aurein 2.2-Δ6 GLFDIVKKVV N12
GMS L(D-)FPVOL(D-)FPVOlayer of paraﬁlm and placed in plastic sheathing before data
acquisition.
Oriented CD samples were prepared in a similar fashion as
described above. The peptide amount was kept constant at 0.5 μmol
and mixed with appropriate molar ratios of lipids and sonicated in
2.0 ml of ddH2O. Each mixture was deposited in 90.0 μl portions onto
3.0 cm×1.0 cm and 1.0 mm thick quartz slides, cleaned thoroughly
with ddH2O and ethanol prior to sample preparation. Clear layers of
samples were observed on the slides after indirect hydration of the
samples. Prior to CD spectral acquisition, each sample was covered
with a second slide with a spacer (six layers of stacked paraﬁlm in a
rectangular 3.0 cm×1.0 cm frame with 2.0 mm width) in between.
2.2.5. Circular dichroism
Solution and oriented CD experiments were carried out using a
JASCO J-810 spectropolarimeter (Victoria, BC) at 30 °C as previously
described [43]. Brieﬂy, the spectra were obtained over a wavelength
range of 190–250 nm, using continuous scanning mode with a
response of 1 s with 0.5-nm steps, bandwidth of 1.5 nm, and a scan
speed of 50 nm/min. The signal/noise ratio was increased by acquiring
each spectrum over an average of three scans. Finally, each spectrum
was corrected by subtracting the background from the sample
spectrum. Solution CD samples were placed in a cell (0.1 cm in
length) in 200 μL portions, while the oriented CD samples on quartz
slides (as described above) were directly placed in the sample
compartment. The temperature of the sample compartment was kept
constant by means of a water bath. The CD experiments were
repeated twice in the case of solution CD and three to four times in the
case of OCD. Linear dichroism effects were tested for and found not to
contribute to the signal.
2.2.6. NMR spectroscopy
Solid state 31P NMR experiments on mechanically aligned lipid
bilayer samples were carried out on a Bruker 500-MHz NMR
spectrometer (Milton, ON) at 30 °C, operating at a phosphorus
frequency of 202.40 MHz as previously reported [43]. The 90° pulse
was set to 11.25 μs for all samples, and a 3 s recycle delay was used.
The spectra were acquired using 2048 scans and processedwith 50 Hz
line-broadening.
2.2.7. MIC determination
Minimal inhibitory concentrations (MIC) for L13A, L13F, L13V,
aurein 2.2-Δ3, and aurein 2.2-Δ6 were determined based on the
previously described modiﬁed methodology [44]. Brieﬂy, 18 h
cultures of B. cereus C737 grown in Mueller Hinton (MH) medium
(Difco, Oakville, ON) were diluted to ~2×105 CFU/ml. 90 μl of diluted
culture was then dispensed into a 96-well polystyrene microtitre
plate (Costar, Cambridge, MA). Separately, two-fold serial dilutions in
sterile MH broth of the respective peptide were carried out at 10×
ﬁnal concentration before 10 μl of each dilution was transferred to theeptides and gramicidin S (GMS) (control) against B. cereus, P. aeruginosa, and E. coli (see
ed from repeat experiments.
(μg/ml)










Fig. 1. Secondary structural content of aurein 2.2, aurein 2.3, and aurein 2.3-COOH in
1:1 POPC/POPG (mol/mol), 1:1 CL/POPG (mol/mol), and 1:1 POPE/POPG (mol/mol)
SUVs: percentage α-helical and random coil content were plotted as a function of P/L
molar ratios and peptides in the presence of (a) 1:1 POPC/POPG (mol/mol), (b) 1:1 CL/
POPG (mol/mol), and (c) 1:1 POPE/POPG (mol/mol) SUVs. The plots show that for all
membrane compositions, the percentage of α-helical content decreased and the
percentage of random coil content increased as the P/L ratio decreased.
625J.T.J. Cheng et al. / Biochimica et Biophysica Acta 1808 (2011) 622–633culture and grown for 18 h at 37 °C before being read. The MIC was
recorded as the lowest concentration of peptide in which no visible
growth could be observed. In addition, culture only and broth only
wells were used. The same procedure was used for cultures of
P. aeruginosa PA01 and E. coli K-12 strain UB1005.
3. Results
3.1. Secondary structure of aurein peptides
To verify that aurein peptides remained structured in the presence
of different lipid membranes, solution CD experiments were performed
in 1:1 CL/POPG (mol/mol) and 1:1 POPE/POPG (mol/mol) small
unilamellar vesicles (SUVs).
Fig. S1 shows solution CD results of aurein 2.2, aurein 2.3 and
aurein 2.3-COOH in 1:1 CL/POPG (mol/mol) and 1:1 POPE/POPG (mol/
mol) SUVs. All spectra demonstrated a maximum at 195 nm and two
minima at 207 nm and 222 nm, which is characteristic of α-helical
structures. This demonstrates that these aurein peptides adopt an
α-helical conformation, regardless of the speciﬁc membrane compo-
sition. As previously observed [43], similar intensities were found at all
peptide-to-lipid molar ratios (P/L=1:15, 1:50, and 1:100) studied,
indicating that maximum binding of the peptide to the lipid vesicles
occurred [2]. The solution CD spectra for the ﬁve aurein variants in 1:1
CL/POPG (mol/mol) and 1:1 POPE/POPG (mol/mol) SUVs were similar
to those obtained for aurein 2.2, aurein 2.3, and aurein 2.3-COOH
(Figs. S2 and S3). This indicates that all the aurein peptides
predominantly adopted an α-helical structure in all lipid environ-
ments tested to date [22,23].
To determine the secondary structural content of the aurein
peptides in CL/POPG and POPE/POPG SUVs, all spectra were ﬁtted
using the three different programs CDSSTR [45], CONTINLL [46], and
SELCON3 [47–50]. Fig. 1 shows the percentage helical and random coil
content as a function of P/L ratios for aurein 2.2, aurein 2.3, and aurein
2.3-COOH in CL/POPG (Fig. 1b) and POPE/POPG (Fig. 1c). Previous
results in POPC/POPG (Fig. 1a) are reproduced here for direct
comparison [22]. The results showed that the percentage of α-helical
content decreased and the percentage of random coil content
increased as the P/L molar ratio decreased, for all lipid compositions.
At high peptide concentrations, aurein 2.2, aurein 2.3, and aurein 2.3-
COOH adopted close to 100% α-helical conformation, in all cases. At
lower peptide concentrations, however, differences in helical content
were observed. At a 1:100 P/L ratio, the three peptides adopted ca. 64–
74% helical structure in POPC/POPG, 34–54% helical structure in CL/
POPG, and 60–73% helical structure in POPE/POPG. Overall, the data
show that the structures of the aurein 2.2, aurein 2.3, and aurein 2.3-
COOHwere retained, but the structural content was dependent on the
molar concentrations examined and also on lipid composition, in
particular when cardiolipin was present.
Fig. 2 shows the percentage of secondary structure content as a
function of P/L ratios for the ﬁve aurein variants: L13A, L13V, L13F,
aurein 2.2-Δ3, and aurein 2.2-Δ6. The results again showed that the
percentage of α-helical content decreased and the percentage of
random coil content increased as the P/L molar ratio decreased, for all
lipid compositions. At low peptide concentrations, the results suggest
that the helical content is slightly higher for POPE/POPG membranes,
followed by POPC/POPG, and then CL/POPG SUVs.
3.2. Membrane insertion states of aurein peptides
Understanding how the aurein peptides interact with different
model bacterial membranes is crucial to elucidating the effect of
membrane composition on the extent of peptide insertion into the
lipid bilayers. OCD experiments were conducted to investigate the
peptide insertion proﬁles in 1:1 CL/POPG (mol/mol) and 1:1 POPE/
POPG (mol/mol) bilayers. For both OCD and 31P solid state NMR (seefollowing section), samples were prepared in similar fashion so that
the data sets could be compared directly and also to verify that the
samples were aligned. All experiments were conducted at 30 °C
(liquid crystalline phase) for consistent comparisonwith our previous
studies. In addition, experiments were repeated at least twice to
ensure the reproducibility of the results.
Fig. 3 shows the OCD results for aurein 2.2, aurein 2.3, and aurein
2.3-COOH in 1:1 CL/POPG (mol/mol) and 1:1 POPE/POPG (mol/mol)
bilayers as a function of P/L ratios. The spectra were normalized such
that all intensities at 222 nm had the same value. The spectra show
that these three peptides had similar insertion proﬁles in CL/POPG
bilayers as in 1:1 POPC/POPG (mol/mol) bilayers [22] but had
dramatically different insertion proﬁles in POPE/POPG bilayers. In
the presence of POPE/POPG, both aurein 2.2 and aurein 2.3 showed a
Fig. 2. Secondary structural content of the ﬁve aurein variants in 1:1 POPC/POPG (mol/
mol), 1:1 CL/POPG (mol/mol), and 1:1 POPE/POPG (mol/mol) SUVs: percentage α-
helical and random coil content were plotted as a function of P/L molar ratios and
peptides in the presence of (a) 1:1 POPC/POPG (mol/mol); (b) 1:1 CL/POPG (mol/mol);
and (c) 1:1 POPE/POPG (mol/mol) SUVs. The plots show that for all membrane
compositions, the percentage of α-helical content decreased and the percentage of
random coil content increased as the P/L ratio decreased.
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proportion of the signal being characteristic of that observed for the
surface adsorbed state (S-state). The peptide aurein 2.3-COOH
remained fully in the S-state over the concentration ranges probed
here. This indicates that aurein 2.2, aurein 2.3, and aurein 2.3-COOH
behaved similarly in POPC/POPG and CL/POPG bilayers, but not in
POPE/POPG bilayers.
Fig. 4 shows the OCD results for the ﬁve aurein variants in 1:1
POPE/POPG (mol/mol) bilayers as a function of P/L ratios. The spectra
showed that L13A, L13F, and aurein 2.2-Δ6 inserted into POPE/POPG
bilayers at threshold P/L molar ratios between 1:15 and 1:80, and
become surface adsorbed at P/L ratios greater than 1:80. Aurein 2.2-Δ3 and L13V did not insert at all P/L ratios examined. This is in stark
contrast to what was previously observed in 1:1 POPC/POPG (mol/
mol) bilayers, where L13V, L13F, and aurein 2.2-Δ3 inserted at low
peptide concentrations, which is consistent with the ability of these
peptides to kill S. aureus via membrane perturbation (cf. [23]). Aurein
2.2-Δ6, on the other hand, had a similar insertion proﬁle as previously
observed in POPC/POPG bilayers. Generally all aurein variants
inserted less readily into POPE/POPG membranes than into POPC/
POPG membranes, with the exception of aurein 2.2-Δ6. Overall, these
data illustrate that the choice of the different model bacterial
membranes had a signiﬁcant impact on the observed aurein peptide
insertion proﬁles.3.3. Lipid headgroup perturbation by the aurein peptides
31P NMR spectra were recorded for aurein 2.2, aurein 2.3, and
aurein 2.3-COOH in 1:1 CL/POPG (mol/mol) and 1:1 POPE/POPG (mol/
mol) bilayers (Figs. 5 and 6). The 31P NMR experiments were
conducted to determine whether the insertion of the peptides was
accompanied by a perturbation of the lipid headgroups and whether
this membrane disruption occurred via a barrel-stave model, carpet
model, or toroidal pore model [51–55]; a micellar aggregate channel
model [56,57]; or a detergent-like mechanism [21].
In the absence of aurein 2.2, aurein 2.3, or aurein 2.3-COOH, the
spectra of 1:1 CL/POPG (mol/mol) bilayers consisted of a single peak
at ~8.7 ppm, which indicated that the lipid bilayers were aligned with
their normal parallel to the magnetic ﬁeld and that the headgroups
were somewhat mobile due to the scaled shift (Fig. 5). 31P NMR
spectra of CL/POPG multilamellar vesicles consisted of a line at
8.7 ppm superimposed on a powder pattern spanning the range of -10
to 30 ppm, reminiscent of the spectra seen in Fig. 5d. Spectra of
aligned CL or POPG alone consisted of a single sharp line at 8.7 ppm.
This suggests that our preparation of aligned samples containing CL
and/or POPG yields aligned hydrated ﬁlms where a certain degree of
headgroup mobility is maintained. In the presence of the three
peptides, the spectra showed slightly increased powder pattern signal
in the -10 to 30 ppm range, indicative that the peptides perturb the
lipid alignment. The proportion of the powder pattern signal
increased as the peptide concentration increased (see ﬁgure caption
for proportion of unaligned signal [10,58]). This indicates that the
membrane disordering was concentration-dependent. At high pep-
tide concentrations, all aurein parents showed a relatively similar
extent of disordering. At low peptide concentrations, aurein 2.2
exhibited a more disruptive effect than aurein 2.3 and aurein 2.3-
COOH. In the presence of aurein 2.3-COOH at low concentrations, only
slightly broadened peaks were observed. This suggests that aurein
2.3-COOH did not have a signiﬁcant disordering effect on CL/POPG
bilayers, which is consistent with our previous 31P NMR results in 4:1
POPC/POPG bilayers [22].
In the absence of aurein 2.2, aurein 2.3 or aurein 2.3-COOH, the
spectra of POPE/POPG bilayers consisted primarily of two single
resonances at 30 ppm (PE) and 15 ppm (PG), which indicated that the
lipid bilayers were aligned with their normal parallel to the magnetic
ﬁeld (Fig. 6). In the presence of each of the three peptides, however,
the spectra showed slightly broadened peaks at 30 ppm, indicating
increased contribution from unaligned 31P headgroups. In addition, a
powder pattern signal was also observed in the -10 to 30 ppm range,
indicative of random headgroup orientations (see ﬁgure caption for
proportion of unaligned signal [10,58]) (Fig. 6). The membrane
disordering effect was again found to be concentration-dependent
and peptide-speciﬁc. At high peptide concentrations, the spectra
consisted mostly of signal arising from a powder pattern, and the
effect was more prominent for aurein 2.2 than the other two peptides.
If one were to correlate the trends observed here to activity, then one
would expect that aurein 2.2 was more effective at killing Gram
Fig. 3. Oriented CD spectra of aurein 2.2, aurein 2.3, and aurein 2.3-COOH in 1:1 CL/POPG (mol/mol) (left panels) and 1:1 POPE/POPG (mol/mol) (right panels) bilayers: (a and d)
aurein 2.2; (b and e) aurein 2.3; and (c and f) aurein 2.3-COOH (P/L molar ratios=1:15 (blue), 1:80 (red), and 1:120 (green)). The spectra were normalized such that intensities of all
spectra at 222 nm are the same. The spectra show that the insertions of these three aurein peptides into 1:1 CL/POPG (mol/mol) bilayers in similar as in 1:1 POPC/POPG (mol/mol)
bilayers [22]. In the presence of 1:1 POPE/POPG (mol/mol) bilayers, these aurein peptides retain a lot of the S-state characteristics at all the P/L ratios tested here.
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which are equally effective.
When the ﬁve different aurein variants were added to 1:1 POPE/
POPG (mol/mol) bilayers, different effects on the bilayer headgroups
were observed. When the L13 variants (i.e. L13A, L13V, and L13F)
were added at high concentrations, the spectra showed an increased
contribution from an underlying powder pattern (see ﬁgure caption
for proportion of unaligned signal [10,58]) (Fig. 7). At low peptide
concentrations, the sizes of the powder pattern were relatively
similar. Note that in the presence of the L13V mutant at high
concentrations, the powder pattern increased signiﬁcantly. This
suggests that at this concentration, the L13V mutant may be more
disruptive to the bilayer headgroup alignment than the other variants,
an observation also made for L13V in 4:1 POPC/POPG (mol/mol)
bilayers. When the C-terminally truncated variants were added at
high concentrations, the spectra again showed enlarged underlying
powder pattern (see ﬁgure caption for proportion of unaligned signal
[10,58]) (Fig. 8). At low peptide concentrations, the sizes of the
powder pattern decreased as the aurein 2.2-Δ3 concentration
decreased, but stayed relatively constant for aurein 2.2-Δ6. Overall,
the trends observed for the mutant peptides in POPE/POPG are
reminiscent of those seen in POPC/POPG bilayers. This suggestsperhaps that membrane perturbation was mainly driven by electro-
static interactions between the positively charged peptides and the
negatively charged PG headgroups, and was less dependent on the
composition of the partner lipid, i.e. be it PC or PE [59].
Taken together, the presence of powder patterns in the 31P NMR
data suggests that all aurein peptides disorder the bilayer headgroups
by forming toroidal pores or disordered pores as found in the
aggregate model [51–55], be that in POPC/POPG, CL/POPG, or POPE/
POPG membranes. The extent of the membrane perturbation was
found to be strongly concentration-dependent and partly dependent
on the nature of the peptide.
3.4. Antimicrobial activity of the aurein peptides
MICs of the aurein 2.2, aurein 2.3, aurein 2.3-COOH and the ﬁve
additional aurein peptides against B. cereus, P. aeruginosa, and E.coli
were determined. The MICs, reported in Table 1, indicated that all the
aurein peptides had very low to no activities against these bacterial
strains, in contrast to our observations in S. aureus [43]. The MICs
determined for both aurein 2.2 and 2.3 against B. cereus were
consistent with previously reported literature values [60]. The MIC
results suggest that the aurein peptides are ineffective against bacteria
Fig. 4. Oriented CD spectra of the ﬁve aurein variants in 1:1 POPE/POPG (mol/mol) bilayers: (a) L13A, (b) L13F, (c) L13V, (d) aurein 2.2-Δ3, and (e) aurein 2.2-Δ6 (P/L molar
ratios=1:15 (blue), 1:80 (red), and 1:120 (green)). The spectra were normalized such that intensities of all spectra at 222 nm are the same. The spectra show that the aurein
variants inserted into 1:1 POPE/POPG (mol/mol) bilayers at threshold P/L molar ratios between 1:15 and 1:80 for L13A, L13F and aurein 2.2-Δ6, and remained in the S-state for L13V
and aurein 2.2-Δ3. These results were signiﬁcantly different from those obtained in 1:1 POPC/POPG (mol/mol) bilayers.
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correlated with the oriented CD and 31P NMR results obtained in
POPE/POPG model membranes.
4. Discussion
A critical step in unlocking the mechanism of action of a given
antimicrobial peptide is to understand how membrane composition
modulates structure and peptide–lipid interactions. In this contribu-
tion, we have further investigated how two antimicrobial peptides
from the Australian Southern Bell frog Litoria aurea, namely aurein 2.2
and aurein 2.3, and some of their variants interact with a range of
currently used model bacterial membranes. We have also examined
the peptide–lipid interaction of the inactive analogue aurein 2.3-
COOH.
Bacterial membrane composition varies from bacteria to bacteria
and also as a response to changing environment [61,62] and to
exposure to antibiotics [63–65]. It is well known that different
bacterial strains can have uniquemembrane compositions [27,65–70].
For example, Gram positive bacteria have a membrane composition
that is different from their Gram negative counterparts [42]. Even
among the Gram positive bacteria themselves, different membrane
compositions have been identiﬁed. Both S. aureus and S. pneumoniahave ~50:50 CL/PG (% of total lipids), whereas B. cereus and B.
anthracis have ~43:40 PE/PG (% of total lipids). A slightly higher
percentage of PE in the total membrane lipids was found for B.
polymyxa (~60%), whereas as high as 70% PG was detected from B.
subtilis. For Gram negative bacteria, E. coli, E. cloacae, P. mirabilis, and
K. pneumonia have ~80% PE, whereas Y. kristensenii and P. aeruginosa
have ~60% PE (with PG being the next highest constituent). Most
Gram negative bacteria have a relatively low percentage of CL.
Since S. aureus is the main antimicrobial target for the aurein
peptides, incorporating CL and PG intomodel membranes is necessary
to replicate biologically relevant membranes. Alternatively, a 1:1
mixture of PE/PGmay be another ideal modelmembrane, in particular
to mimic bacteria such as B. cereus and B. anthracis. Choosing the
correct source of the lipids (i.e. natural versus synthetic) is important.
In order to have a well deﬁned membrane, synthetic lipids are often
selected since these lipids can be obtained in pure form. Thus the
POPC, POPG and POPE used in this study were synthetic. For CL, the
only readily available synthetic forms are tetramyristoylcardiolipin
(TMCL), tetrapalmitoylcardiolipin (TPCL), and tetraoleoylcardiolipin
(TOCL). The high Tm of TMCL (~47 °C), TPCL (~62 °C) [71], and E. coli
cardiolipins [72] would require experiments to be conducted at the
high temperatures needed to achieve the liquid crystalline phase and
make comparison of data obtained at 30 °C for POPC/POPG or POPE/
Fig. 5. Solid state 31P NMR spectra of mechanically aligned 1:1 CL/POPG (mol/mol) bilayers containing aurein 2.2, aurein 2.3, and aurein 2.3-COOH: (a) CL/POPG bilayers alone, P/L=
(b) 1:120, (c) 1:80, and (d) 1:15 in the presence of aurein 2.2 (left panel), aurein 2.3 (centre panel), and aurein 2.3-COOH (right panel). The spectra were recorded using 2048 scans
at 30°C, oriented such that the normal bilayer was parallel to the external magnetic ﬁeld. The spectra were processed with 50 Hz line-broadening. At P/L ratios of 1:15, the proportion
of unaligned lipids increases by 63% for aurein 2.2, 63% for aurein 2.3, and 71% for aurein 2.3-COOH. These percentages are determined by ﬁtting the spectra using 1 Gaussian/
Lorentzian lines and 1 31P CSA static line in DMFIT [84] and integrating.
Fig. 6. Solid state 31P NMR spectra of mechanically aligned 1:1 POPE/POPG (mol/mol) bilayers containing aurein 2.2, aurein 2.3, and aurein 2.3-COOH: (a) POPE/POPG bilayers alone,
P/L=(b) 1:120, (c) 1:80, and (d) 1:15 in the presence of aurein 2.2 (left panel), aurein 2.3 (centre panel), and aurein 2.3-COOH (right panel). The spectra were recorded using 2048
scans at 30°C, oriented such that the normal bilayer was parallel to the external magnetic ﬁeld. The spectra were processed with 50 Hz line-broadening. At P/L ratios of 1:15, the
proportion of unaligned lipids increases by 40% for aurein 2.2, 15% for aurein 2.3, and 24% for aurein 2.3-COOH. These percentages are determined by ﬁtting the spectra using 2
Gaussian/Lorentzian lines and 1 31P CSA static line in DMFIT [84] and integrating.
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Fig. 7. Solid state 31P NMR spectra of mechanically aligned 1:1 POPE/POPG (mol/mol) bilayers containing the three L13 aurein variants: (a) POPE/POPG bilayers alone, P/L=(b)
1:120, (c) 1:80, and (d) 1:15 in the presence of L13A (left panel), L13F (centre panel), and L13V (right panel). The spectra were recorded using 2048 scans at 30 °C, oriented such that
the normal bilayer was parallel to the external magnetic ﬁeld. The spectra were processed with 50 Hz line-broadening. At P/L ratios of 1:15, the proportion of unaligned lipids
increases by 30% for L13A, 40% for L13F, and 59% for L13V. These percentages are determined by ﬁtting the spectra using 2 Gaussian/Lorentzian lines and 1 31P CSA static line in DMFIT
[84] and integrating.
630 J.T.J. Cheng et al. / Biochimica et Biophysica Acta 1808 (2011) 622–633POPGwith data obtained at higher temperatures for CL/POPG difﬁcult.
TOCL or bovine heart CL are more attractive alternatives, with a Tm
below 0°C [73]. In this study, we therefore chose to use a bovine heart
CL:POPG mixture as a model membranes for S. aureus [74]. A control
CD experiment using aurein 2.2 in 1:1 TOCL/POPG (mol/mol) (data
not shown) yielded the same results as those obtained for 1:1 bovine
heart CL/POPG shown in Fig. 1b.
It is widely accepted that most cationic antimicrobial peptides
adopt deﬁned secondary structures only in the presence of mem-
branes [51,75,76], and that the adoption of secondary structure is a
key ﬁrst step during membrane interaction. Our solution CD results
demonstrated that the eight aurein peptides tested here maintain
their predominantly α-helical structure in 1:1 CL/POPG (mol/mol)
and 1:1 POPE/POPG (mol/mol) as well as in 1:1 POPC/POPG [22] SUVs.
This is particularly true for P/L ratios of 1:50 or higher. Very few
studies have demonstrated that amphibian antimicrobial peptides
preserve their predominant conformation in both POPC/POPG and
POPE/POPG membranes. To the best of our knowledge, only one
molecular dynamics (MD) simulation and lipid vesicle study has
shown that buforin II (BF2), an α–helical antimicrobial peptide from
the asian toad Bufo bufo gargarizans, maintains its predominant
structure in both POPC/POPG and POPE/POPG membranes [77]. The
presence of PE does not alter secondary structure, nor does it abolish
the ability of a peptide to bind to the lipid membranes. A recent
review of protegrin-1 (PG-1) demonstrated analogous observations in
that PG-1 preserves its β-sheet structure in POPC/Chol bilayers as well
as in POPE/POPG bilayers [9]. The solution CD data on the aurein
peptides has demonstrated that the choice of PC versus CL versus PE in
bacterial model membranes has consequences only for the structural
content, but not for the overall structure of the peptide. Indeed, at low
peptide concentrations, the aurein peptides generally were less
helical in CL/PG, followed by PC/PG, and ﬁnally, PE/PG (Figs. 1 and
2; P/L=1:100). The study of BF2 also demonstrated that the presenceof PE induced a higher percentage of helical content in BF2 than PC
[77]. The higher percentage of helicity, however, does not necessarily
correlate with higher antimicrobial activity or greater ability to
disorder membranes. Indeed, a recent study of four α-helical
antimicrobial peptides indicated that ﬂexibility in the structure can
actually promote better peptide association into toroidal pores and
thus better toroidal pore formation [78]. Overall, the structural
ﬁndings suggest that the presence of secondary structure cannot
necessarily be used as an indicator of how well a given antimicrobial
peptide will interact with different lipids.
Cationic antimicrobial peptides interact with bacterial membranes
mainly through electrostatic interactions with the PG headgroups
[28,52]. If, however, the interaction with the PG headgroups were the
only governing factor, then one would expect that the exact nature of
additional lipid components would be irrelevant. The OCD data
presented here suggests that the choice of PC versus CL versus PE
plays a signiﬁcant role in the ability of the aurein peptides to insert.
Indeed, aurein 2.2, aurein 2.3, and aurein 2.3-COOH inserted much
less readily into POPE/POPG bilayers, than POPC/POPG or CL/POPG
membranes, which were roughly equivalent. Our OCD results on all
ﬁve aurein variants further support this ﬁnding. Studies have
suggested that PE/PG bilayers have stronger headgroup–headgroup
interactions than PC/PG (and presumably also CL/PG), because the
shapes of PE and PG are more complementary. Tighter lipid packing
will of course impede peptide insertion [59]. The choice of PC versus
CL versus PE appears to play less of a role however in how the aurein
peptides perturb the lipid headgroups. The 31P NMR data suggested
that all aurein peptides disordered the bilayer headgroups by forming
of interactions reminiscent of distorted toroidal pores [51–55], be that
in POPC/POPG, CL/POPG, or POPE/POPG membranes. The extent of
membrane perturbation is only found to be strongly concentration-
dependent and partially dependent on the nature of the peptide. In
the literature, several quite diverse antimicrobial peptides perturb
Fig. 8. Solid state 31P NMR spectra of mechanically aligned 1:1 POPE/POPG (mol/mol)
bilayers containing the two C-terminally truncated aurein variants: (a) POPE/POPG
bilayers alone, P/L=(b) 1:120, (c) 1:80, and (d) 1:15 in the presence of aurein 2.2-Δ3
(left panel) and aurein 2.2-Δ6 (right panel). The spectra were recorded using 2048
scans at 30 °C, oriented such that the normal bilayer was parallel to the external
magnetic ﬁeld. The spectra were processed with 50 Hz line-broadening. At P/L ratios of
1:15, the proportion of unaligned lipids increases by 31% for aurein 2.2-Δ3 and 40% for
aurein 2.2-Δ6. These percentages are determined by ﬁtting the spectra using 2
Gaussian/Lorentzian lines and 1 31P CSA static line in DMFIT [84] and integrating.
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POPE, and POPE/POPG bilayers. Examples include MSI-78 [27,81,82],
KIGAKI [83], and PG-1 [8–10].
As the MIC data show, the aurein peptides were not very active
against bacteria that contain ~40–60% PE, namely bacteria like B.
cereus and P. aeruginosa. The biophysical data correlated with this low
activity since for 1:1 POPE/POPG, all the aurein peptides are found to
insert into PE/PG membranes to a lesser extent than PC/PG. The high
helicity found in POPE/POPG suggests that secondary structure per se
cannot be used as an indicator of activity. For completeness, theMIC of
each aurein peptide was determined for E.coli (80% PE), as well as the
effect of the peptides on 4:1 POPE/POPG headgroups using 31P NMR
on aligned bilayers (Figs. S4 and S5). Interestingly, the data suggested
that certain of the aurein peptides had some minimal level of activity,
yet did not perturb the lipid headgroups as well as when the peptides
were in 1:1 POPE/POPG. Therefore, in this case, one would have to
conclude that a membrane model of 4:1 POPE/POPG (or even 1:1
POPE/POPG) would be inadequate for determining the mode of action
of the aurein peptides that showed some minimal activity against E.
coli. In addition, the minimal perturbation seen in 4:1 POPE/POPG
model membranes and the residual activity observed might suggest
that the aurein peptides may affect E. coli by acting on some internal
target, rather than perturbing the membrane directly. Nevertheless,
the MIC data determined previously against S. aureus [43] showed
that the aurein peptides are quite effective at killing these bacteria
and that 1:1 POPC/POPG or 1:1 CL/POPG bilayers are a good choice as
model membranes for this bacteria.
Understanding the behavior of a given amphibian antimicrobial
peptide in both intact bacteria andmodel membranes can reveal what
is the basis for activity against certain bacteria and is important in anyfuture design of better antimicrobial agents. For the aurein peptides, a
good model for understanding how these peptides act on S. aureus is
1:1 POPC/POPG or 1:1 CL/POPG. For B. cereus, model membranes of
1:1 POPE/POPG are a good choice. In conclusion, speciﬁc model
membranes should be used to model speciﬁc bacteria, given the
unique membrane composition of individual bacterial species.
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